DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Miura Y, Yamamoto N, Tsunekawa S, Taguchi S, Eguchi Y, Ozaki N, Oiso Y.
Replacement of valsartan and candesartan by telmisartan in hypertensive patients with type 2 diabetes: metabolic and antiatherogenic consequences.
Diabetes Care 2005; 28: 757-758
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.